Theoretical versus empirical allometry: Facts behind theories and application to pharmacokinetics

Journal of Pharmaceutical Sciences

Volumn 99, Issue 7, 2010, Pages 2927-2933

  Mahmood, Iftekhar ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Clearance; Hepatic clearance; Pharamcokinetics; Population pharmacokinetics; Renal excretion

Indexed keywords

ALLOMETRY; BASAL METABOLIC RATE; BIOLOGY; BODY SIZE; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; NOTE; PHYSIOLOGICAL PROCESS; PREDICTION; THEORETICAL STUDY;

EID: 77953311159     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22073     Document Type: Note

References (46)

1. Chappell WR, Mordenti J. 1991. Extrapolation of toxicological and pharmacological data from animals to humans. Adv Drug Res 20:1-116.
2. Kleiber M. 1932. Body size and metabolism. Hilgardia 6:315.
3. Kleiber M. 1961. The fire of life: An introduction to animal energetics. New York: Wiley.
4. Brody S, Procter RC, Ashworth US. 1934. Basal metabolism, endogenous nitrogen, creatinine and neutral sulphur excretions as functions of body weight. Univ Mo Agric Exp Stn Res Bull 220:1-40.
5. Brody S. 1945. Bioenergetics and growth, with special reference to the efficiency complex in domestic animals. London: Hafner Press, New York, and MacMillan Publishers.
6. West GB, Brown JH, Enquist BJ. 1997. A general model for the origin of allometric scaling laws in biology. Science 276:122-126. (Pubitemid 27161259)
7. West GB, Brown JH, Enquist BJ. 1999. The fourth dimension of life: Fractal geometry and allometric scaling of organisms. Science 284:1677-1679.
8. Petit G, Anfodillo T. 2009. Plant physiology in theory and practice: An analysis of the WBE model for vascular plants. J Theor Biol 259:1-4.
9. Heusner AA. 1982. Energy metabolism and body size I. Is the 0.75 mass exponent of Kleiber's equation a statistical artifact? Resp Physiol 48:13-25.
10. Hayssen V, Lacy RC. 1985. Basal metabolic rates in mammals: Toxonomic differences in the allometry of BMR and body mass. Comp Biochem Physiol 81A:741-754.
11. Glazier DS. 2005. Beyond the '3/4-power law': Variation in the intra- and interspecific scaling of metabolic rate in animals. Biol Rev Camb Philos Soc 80:611-662.
12. Packard GC, Birchard GF. 2008. Traditional allometric analysis fails to provide a valid predictive model for mammalian metabolic rates. J Exp Biol 211:3581-3587.
13. Duncan RP, Forsyth DM, Hone J. 2007. Testing the metabolic theory of ecology: Allometric scaling exponents in mammals. Ecology 88:324-333. (Pubitemid 46596795)
14. Bokma F. 2004. Evidence against universal metabolic allometry. Funct Ecol 18: 184-187. (Pubitemid 38504281)
15. White CR, Seymour RS. 2005. Sample size and mass range effects on the allometric exponent of basal metabolic rate. Comp Biochem Physiol A Mol Integr Physiol 142:74-78.
16. White CR, Cassey P, Blackburn TM. 2007. Allometric exponents do not support a universal metabolic allometry. Ecology 88:315-323. (Pubitemid 46596794)
17. Savage VM, Deeds EJ, Fontana W. 2008. Sizing up allometric scaling theory. PLos Comput Biol 4:e1000171.
18. White CR, Blackburn TM, Seymour RS. 2009. Phylogenetically informed analysis of the allometry of mammalian basal metabolic rate supports neither geometric nor quarter-power scaling. Evolution 63: 2658-2667.
19. Bejan A. 2005. The constructal law of organization in nature: Tree-shaped flows and body size. J Exp Biol 208:1677-1686. (Pubitemid 40697616)
20. Dodds PS, Rothman DH, Weitz JS. 2001. Re-examination of the "3/4-law" of metabolism. J Theor Biol 209:9-27.
21. Adolph EF. 1949. Quantitative relations in the physiological constitutions of mammals. Science 109:579-585.
22. Ritschel WA, Banerjee PS. 1986. Physiological pharmacokinetic models: Principles, applications, limitations and outlook. Methods Find Expt Clin Pharmacol 8:603-614.
23. Chiou WL, Robbie G, Chung SM, Wu TC, Ma C. 1998. Correlation of plasma clearance of 54 extensively metabolized drugs between humans and rats: Mean allometric coefficient of 0.66. Pharm Res 15:1474-1479. (Pubitemid 28427939)
24. Karalis V, Macheras P. 2002. Drug disposition viewed in terms of the fractal volume of distribution. Pharm Res 19:696-703. (Pubitemid 34553680)
25. Mahmood I. 2005. Interspecies scaling of clearance. In: Interspecies pharmacokinetic scaling. Principles and application of allometric scaling. Rockville, MD: Pine House Publishers. pp. 39-85.
26. Mahmood I. 2009. Application of fixed exponent 0.75 to the prediction of human drug clearance: An inaccurate and misleading concept. Drug Metab Drug Interact 24:57-81.
27. Wieser W. 1984. A distinction must be made between the ontogeny and the phylogeny of metabolism in order to understand the mass exponent of energy metabolism. Resp Physiol 55:1-9. (Pubitemid 14190805)
28. Mahmood I. 2006. Prediction of drug clearance in children from adults: A comparison of several allometric methods. Br J Clin Pharmacol 61:545-557.
29. Mahmood I. 2007. Prediction of drug clearance in children: Impact of allometric exponents, body weight and age. Ther Drug Monit 29:271-278. (Pubitemid 47262255)
30. Mahmood I. 2008. Prediction of pharmacokinetic parameters in children: Application of allometric principles. In: Pediatric pharmacology and pharmacokinetics. Rockville, MD: Pine House Publishers. pp. 142-183.
31. Grasela TH, Sheiner LB, Rambeck B, Boenigk HE, Dunlop A, Mullen PW, Wadsworth J, Richens A, Ishizaki T, Chiba K. 1983. Steady-state pharmacokinetics of phenytoin from routinely collected patient data. Clin Pharmacokinet 8: 355-364. (Pubitemid 13069552)
32. El-Tahtawy A, Kokki H, Reidenberg BE. 2006. Population pharmacokinetics of oxycodone in children 6 months to 7 years old. J Clin Pharmacol 46:433-442.
33. Trenque T, Simon N, Villena I, Chemla C, Quereux C, et al. 2004. Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis. Br J Clin Pharmacol 57:735-741. (Pubitemid 38748041)
34. Aumente D, Buelga DS, Lukas JC, Gomez P, Torres A, Garcia MJ. 2006. Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia. Clin Pharmacokinet 45:1227-1238. (Pubitemid 44904825)
35. Laer S, Elshoff JP, Meibohm B, Weil J, Mir TS, et al. 2005. Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia. J Am Coll Cardiol 46:1322-1330. (Pubitemid 41615557)
36. Toublanc N, Sargentini-Maier ML, Lacroix B, Jacqmin P, Stockis A. 2008. Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: Dosing recommendations. Clin Pharmacokinet 47: 333-341. (Pubitemid 351508119)
37. Booth BP, Rahman A, Dagher R, Griebel D, Lennon S, et al. 2007. Population pharmacokinetic-based dosing of intravenous busulfan in pediatric patients. J Clin Pharmacol 47:101-111. (Pubitemid 44974004)
38. Serrano BB, Garcia Sanchez MJ, Otero MJ, Buelga DS, Serrano J, Dominguez-Gil A. 1999. Valproate population pharmacokinetics in children. J Clin Pharm Ther 24:73-80.
39. Schuttler J, Ihmsen H. 2000. Population pharmacokinetics of propofol: A multicenter study. Anesthesiology 92:727-738. (Pubitemid 30130176)
40. Peeters MY, Prins SA, Knibbe CA, Dejongh J, van Schaik RH, et al. 2006. Propofol pharmacokinetics and pharmacodynamics for depth of sedation in nonventilated infants after major craniofacial surgery. Anesthesiology 104:466-474. (Pubitemid 44808577)
41. Mahmood I. 2005. Interspecies scaling of volumes of distribution. In: Interspecies pharmacokinetic scaling. Principles and application of allometric scaling. Rockville, MD: Pine House Publishers. pp. 188-205.
42. Dedrick RL, Bischoff KB, Zahrako DZ. 1970. Interspecies correlation of plasma concentration history of methotrexate (NSC-740). Cancer Chemother Rep Part I 54: 95-101.
43. Mahmood I. 2005. Interspecies scaling of elimination half-life and mean residence time. In: Interspecies pharmacokinetic scaling. Principles and application of allometric scaling. Rockville, MD: Pine House Publishers. pp. 206-218.
44. Boxenbaum H. 1984. Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm. Drug Metab Rev 15: 1071-1121. (Pubitemid 15158037)
45. Hoppeler H, Weibel ER. 2005. Scaling functions to body size: Theories and facts. J Exp Biol 208:1573-1574. (Pubitemid 40697605)
46. Knut Schmidt-Nielsen. 1984. Metabolic rate and body size. In: Scaling: Why is animal size so important. Cambridge: Cambridge University Press. pp. 56-74.